Hims & Hers Health, Inc. (HIMS) Misses Q4 EPS by 8c

Hims & Hers Health, Inc. (NYSE: HIMS) reported Q4 EPS of ($0.15), $0.08 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $84.7 million versus the consensus estimate of $76.79 million.

GUIDANCE:

Hims & Hers Health, Inc. sees FY2022 revenue of $365-380 million, versus the consensus of $350 million.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.

You May Also Be Interested In

• Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
• Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance
• UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance